PAREXEL International Corporation introduced PAREXEL's Medical Writing Solutions, a new offering that provides several communication services needed throughout each critical stage of the drug development and commercialization process.
The medical writing solutions team is made up of hundreds of trained experts that develop high quality documents which are compliant with the latest regulations and guidelines in order to drive value for clients.
The offering is currently available as both functional service projects or as part of larger strategic partnerships based on their study needs. For more information visit http://www.parexel.com/medicalwriting.
The Weight-Loss Gold Rush: Legal and Regulatory Implications
July 11th 2024Jim Shehan, chair of the FDA Regulatory practice, Lowenstein Sandler, discusses how the FDA and other regulators likely to respond to the increased public interest and potential off-label use of GLP-1 drugs, what needs to be done for GLP-1s to be covered, advice for investors and financiers considering entering the weight-loss medication market and more.
Healthcare Marketing Strategies for Reaching Diverse Audiences
May 14th 2024Amanda Powers-Han, Chief Marketing Officer, Greater Than One, and Pharmaceutical Executive Editorial Advisory Board member, discusses how improved DE&I in healthcare marketing strategies can not only reach diverse audiences more effectively but also contribute to improved patient care outcomes, challenges faced in crafting culturally sensitive messages, and much more.